Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Sixth Affiliated Hospital, Sun Yat-sen University
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Diagnosed UC for at least 3 months, including endoscopic evidence supporting UC and histopathological evidence supporting UC diagnosis
Suffering from moderate to severe UC, defined as modified Mayo score ≥ 4 and endoscopic subscale (ESS) ≥ 2
Indications for VDZ or UPA application
You may not be if
Patients who are unable to take oral UPA and receive regular intravenous VDZ infusion therapy
Evidence of toxic megacolon was found during screening
Previously underwent extensive colectomy, subtotal resection, or total colectomy, ileostomy, or colostomy due to UC
Subjects who require surgery due to UC or plan to undergo elective surgery during the study period
There is evidence indicating that the subjects suffer from severe, progressive, or uncontrolled kidney, liver, blood, endocrine, respiratory, mental, or neurological diseases
Evidence of active hepatitis B or C infection during screening
Clareo Health | Efficacy and Safety of Vedolizumab Combined With Upadacitinib in Patients With Ulcerative Colitis
